메뉴 건너뛰기
Dermatology
Volumn 230, Issue 2, 2015, Pages 101-104
Fast-growing cutaneous squamous cell carcinoma in a patient treated with vismodegib
Author keywords

Basal cell carcinoma; Squamous cell carcinoma; Vismodegib
Indexed keywords

FLUOROURACIL; VISMODEGIB; ANILIDE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; PYRIDINE DERIVATIVE;
EID: 84924161015     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000368350     Document Type: Article
Times cited : (16)
References (8)
  • 1
    • 84861856844 scopus 로고    scopus 로고
    • Efficacy and safety of vismodegib in advanced basal-cell carcinoma
    • Sekulic A, Migden MR, Oro AE, et al: Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012; 366: 2171-2179.
    • (2012) N Engl J Med , vol.366 , pp. 2171-2179
    • Sekulic, A.1    Migden, M.R.2    Oro, A.E.3
  • 2
    • 84879080132 scopus 로고    scopus 로고
    • Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib
    • Iarrobino A, Messina JL, Kudchadkar R, Sondak VK: Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib. J Am Acad Dermatol 2013; 69:e33-e34.
    • (2013) J Am Acad Dermatol , vol.69 , pp. e33-e34
    • Iarrobino, A.1    Messina, J.L.2    Kudchadkar, R.3    Sondak, V.K.4
  • 3
    • 84983573536 scopus 로고    scopus 로고
    • Product information, (accessed October 24, 2013)
    • European Medicines Agency: Erivedge (vismodegib). Product information. http:// www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product-Information/ human/002602/WC500146817.pdf (accessed October 24, 2013).
    • Erivedge (Vismodegib)
  • 4
    • 85027924456 scopus 로고    scopus 로고
    • Multiple highly and moderately differentiated squamous cell carcinomas of the skin during vismodegib treatment of inoperable basal cell carcinoma
    • Orouji A, Goerdt S, Utikal J, Leverkus M: Multiple highly and moderately differentiated squamous cell carcinomas of the skin during vismodegib treatment of inoperable basal cell carcinoma. Br J Dermatol 2014; 171: 431-433.
    • (2014) Br J Dermatol , vol.171 , pp. 431-433
    • Orouji, A.1    Goerdt, S.2    Utikal, J.3    Leverkus, M.4
  • 5
    • 84908242161 scopus 로고    scopus 로고
    • Two different scenarios of squamous cell carcinoma within advanced basal cell carcinomas: Cases illustrating the importance of serial biopsy during vismodegib usage
    • Zhou GA, Sundram U, Chang AS: Two different scenarios of squamous cell carcinoma within advanced basal cell carcinomas: cases illustrating the importance of serial biopsy during vismodegib usage. JAMA Dermatol 2014; 150: 970-973.
    • (2014) JAMA Dermatol , vol.150 , pp. 970-973
    • Zhou, G.A.1    Sundram, U.2    Chang, A.S.3
  • 6
    • 84876545781 scopus 로고    scopus 로고
    • 'Patch'ing up our tumor signaling knowledge
    • Atwood SX, Whitson RJ, Oro AE: 'Patch'ing up our tumor signaling knowledge. J Invest Dermatol 2013; 133: 1131-1133.
    • (2013) J Invest Dermatol , vol.133 , pp. 1131-1133
    • Atwood, S.X.1    Whitson, R.J.2    Oro, A.E.3
  • 7
    • 33847138972 scopus 로고    scopus 로고
    • Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice
    • Wakabayashi Y, Mao JH, Brown K, et al: Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice. Nature 2007; 445: 761-765.
    • (2007) Nature , vol.445 , pp. 761-765
    • Wakabayashi, Y.1    Mao, J.H.2    Brown, K.3
  • 8
    • 84876558331 scopus 로고    scopus 로고
    • Ptch1 overexpression drives skin carcinogenesis and developmental defects in K14Ptch(FVB) mice
    • Kang HC, Wakabayashi Y, Jen KY, et al: Ptch1 overexpression drives skin carcinogenesis and developmental defects in K14Ptch(FVB) mice. J Invest Dermatol 2013; 133: 1311-1320.
    • (2013) J Invest Dermatol , vol.133 , pp. 1311-1320
    • Kang, H.C.1    Wakabayashi, Y.2    Jen, K.Y.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.